Advertisement

Topics

Alzheimer's Patients may Benefit Significantly From an Array of Diabetes Treatments, Says GBI Research

06:06 EST 1 Dec 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
LONDON, December 1, 2016 /PRNewswire/ -- A new Analyst View from business intelligence provider GBI Research - Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease - states that recent findings have shown that type 2 diabetes mellitus (T2...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Alzheimer's Patients may Benefit Significantly From an Array of Diabetes Treatments, Says GBI Research"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...